Article
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Breast cancer research : BCR - 28 Feb 2011
Kuusisto Kirsi M, Bebel Aleksandra, Vihinen Mauno, Schleutker Johanna, Sallinen Satu-Leena
Abstract excerpt
INTRODUCTION: Two major high-penetrance breast cancer genes, BRCA1 and BRCA2, are responsible for approximately 20% of hereditary breast cancer (HBC) cases in Finland. Additionally, rare mutations in several other genes that interact with BRCA1 and BRCA2 increase the risk of HBC. Still, a majority of HBC cases remain unexplained which is challenging for genetic counseling. We aimed to analyze additional mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.